FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show

2.

Train Eyes so Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke

3.

'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrested

4.

Study offers clearer picture of childhood brain tumor survival

5.

Antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot